Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease.

Lin MT, Cantuti-Castelvetri I, Zheng K, Jackson KE, Tan YB, Arzberger T, Lees AJ, Betensky RA, Beal MF, Simon DK.

Ann Neurol. 2012 Jun;71(6):850-4. doi: 10.1002/ana.23568.

2.

The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression.

Mikkilineni S, Cantuti-Castelvetri I, Cahill CM, Balliedier A, Greig NH, Rogers JT.

Parkinsons Dis. 2012;2012:142372. doi: 10.1155/2012/142372. Epub 2012 May 29.

3.

Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.

Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, Rockenstein E, Masliah E, Hyman BT, McLean PJ, Unni VK.

J Neurosci. 2011 Oct 12;31(41):14508-20. doi: 10.1523/JNEUROSCI.1560-11.2011.

4.

The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.

Rogers JT, Mikkilineni S, Cantuti-Castelvetri I, Smith DH, Huang X, Bandyopadhyay S, Cahill CM, Maccecchini ML, Lahiri DK, Greig NH.

J Neural Transm (Vienna). 2011 Mar;118(3):493-507. doi: 10.1007/s00702-010-0513-5. Epub 2011 Jan 8.

PMID:
21221670
5.

Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.

Cantuti-Castelvetri I, Hernandez LF, Keller-McGandy CE, Kett LR, Landy A, Hollingsworth ZR, Saka E, Crittenden JR, Nillni EA, Young AB, Standaert DG, Graybiel AM.

PLoS One. 2010 Nov 10;5(11):e13861. doi: 10.1371/journal.pone.0013861.

6.

PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease.

Zheng B, Liao Z, Locascio JJ, Lesniak KA, Roderick SS, Watt ML, Eklund AC, Zhang-James Y, Kim PD, Hauser MA, Grünblatt E, Moran LB, Mandel SA, Riederer P, Miller RM, Federoff HJ, Wüllner U, Papapetropoulos S, Youdim MB, Cantuti-Castelvetri I, Young AB, Vance JM, Davis RL, Hedreen JC, Adler CH, Beach TG, Graeber MB, Middleton FA, Rochet JC, Scherzer CR; Global PD Gene Expression (GPEX) Consortium.

Sci Transl Med. 2010 Oct 6;2(52):52ra73. doi: 10.1126/scitranslmed.3001059.

7.

Hypoxia inducible factor-1α (HIF-1α) and some HIF-1 target genes are elevated in experimental glaucoma.

Ergorul C, Ray A, Huang W, Wang DY, Ben Y, Cantuti-Castelvetri I, Grosskreutz CL.

J Mol Neurosci. 2010 Oct;42(2):183-91. doi: 10.1007/s12031-010-9343-z. Epub 2010 Mar 17.

8.

Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy.

Crittenden JR, Cantuti-Castelvetri I, Saka E, Keller-McGandy CE, Hernandez LF, Kett LR, Young AB, Standaert DG, Graybiel AM.

Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2892-6. doi: 10.1073/pnas.0812822106. Epub 2009 Jan 26.

9.

Transcriptional dysregulation in a transgenic model of Parkinson disease.

Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, Asteris G, McLean PJ, Hyman BT, Standaert DG.

Neurobiol Dis. 2008 Mar;29(3):515-28. doi: 10.1016/j.nbd.2007.11.008. Epub 2007 Nov 28.

10.

Effects of gender on nigral gene expression and parkinson disease.

Cantuti-Castelvetri I, Keller-McGandy C, Bouzou B, Asteris G, Clark TW, Frosch MP, Standaert DG.

Neurobiol Dis. 2007 Jun;26(3):606-14. Epub 2007 Mar 3.

11.

Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra.

St Martin JL, Klucken J, Outeiro TF, Nguyen P, Keller-McGandy C, Cantuti-Castelvetri I, Grammatopoulos TN, Standaert DG, Hyman BT, McLean PJ.

J Neurochem. 2007 Mar;100(6):1449-57. Epub 2007 Jan 4.

12.

Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse.

Sadri-Vakili G, Menon AS, Farrell LA, Keller-McGandy CE, Cantuti-Castelvetri I, Standaert DG, Augood SJ, Yohrling GJ, Cha JH.

Eur J Neurosci. 2006 Jun;23(12):3171-5.

PMID:
16820007
13.

No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain.

Ingelsson M, Ramasamy K, Cantuti-Castelvetri I, Skoglund L, Matsui T, Orne J, Kowa H, Raju S, Vanderburg CR, Augustinack JC, de Silva R, Lees AJ, Lannfelt L, Growdon JH, Frosch MP, Standaert DG, Irizarry MC, Hyman BT.

Acta Neuropathol. 2006 Oct;112(4):439-49. Epub 2006 Jun 27.

PMID:
16802167
14.

Alpha-synuclein and chaperones in dementia with Lewy bodies.

Cantuti-Castelvetri I, Klucken J, Ingelsson M, Ramasamy K, McLean PJ, Frosch MP, Hyman BT, Standaert DG.

J Neuropathol Exp Neurol. 2005 Dec;64(12):1058-66.

PMID:
16319716
15.

Somatic mitochondrial DNA mutations in single neurons and glia.

Cantuti-Castelvetri I, Lin MT, Zheng K, Keller-McGandy CE, Betensky RA, Johns DR, Beal MF, Standaert DG, Simon DK.

Neurobiol Aging. 2005 Nov-Dec;26(10):1343-55. Epub 2004 Dec 29.

PMID:
16243605
16.

The effects of heavy particle irradiation on exploration and response to environmental change.

Casadesus G, Shukitt-Hale B, Cantuti-Castelvetri I, Rabin BM, Joseph JA.

Adv Space Res. 2004;33(8):1340-6.

PMID:
15803625
17.

Dopamine neurotoxicity: age-dependent behavioral and histological effects.

Cantuti-Castelvetri I, Shukitt-Hale B, Joseph JA.

Neurobiol Aging. 2003 Sep;24(5):697-706.

PMID:
12885577
18.

Cognitive deficits induced by 56Fe radiation exposure.

Shukitt-Hale B, Casadesus G, Cantuti-Castelvetri I, Rabin BM, Joseph JA.

Adv Space Res. 2003;31(1):119-26.

PMID:
12577981
19.

The spin trapping agent PBN stimulates H2 O2 -induced Erk and Src kinase activity in human neuroblastoma cells.

Kelicen P, Cantuti-Castelvetri I, Pekiner C, Paulson KE.

Neuroreport. 2002 Jun 12;13(8):1057-61.

PMID:
12060808
20.

Expression and activity of antioxidants in the brain in progressive supranuclear palsy.

Cantuti-Castelvetri I, Keller-McGandy CE, Albers DS, Beal MF, Vonsattel JP, Standaert DG, Augood SJ.

Brain Res. 2002 Mar 15;930(1-2):170-81.

PMID:
11879807
21.

Effect of age on object exploration, habituation, and response to spatial and nonspatial change.

Shukitt-Hale B, Casadesus G, Cantuti-Castelvetri I, Joseph JA.

Behav Neurosci. 2001 Oct;115(5):1059-64.

PMID:
11584918
22.

Role of membrane lipids in regulation of vulnerability to oxidative stress in PC12 cells: implication for aging.

Denisova NA, Cantuti-Castelvetri I, Hassan WN, Paulson KE, Joseph JA.

Free Radic Biol Med. 2001 Mar 15;30(6):671-8.

PMID:
11295365
23.

Influence of photoperiod, laboratory caging and aging on plasma lipid response to an atherogenic diet among F1B hamsters.

Smith D, Pedro-Botet J, Cantuti-Castelvetri I, Shukitt-Hale B, Schaefer EJ, Joseph J, Ordovas JM.

Int J Neurosci. 2001;106(3-4):185-94.

PMID:
11264919
24.

Neurobehavioral aspects of antioxidants in aging.

Cantuti-Castelvetri I, Shukitt-Hale B, Joseph JA.

Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):367-81. Review.

PMID:
10817921
25.

Preface

Cantuti-Castelvetri I I, Joseph JA, Algeri S.

Int J Dev Neurosci. 2000 Jul;18(4-5):337. No abstract available.

PMID:
10817917
26.

Differential effect of dopamine catabolism and uptake inhibition on dopamine-induced calcium dysregulation and viability loss.

Cantuti-Castelvetri I, Joseph JA.

Free Radic Biol Med. 1999 Dec;27(11-12):1393-404.

PMID:
10641734

Supplemental Content

Loading ...
Support Center